Iran vs Syria: Treatment for hypertension, male
Iran
37.6%
in 2019
Syria
37.7%
in 2019
Iran rank
82nd
Syria rank
81st
Treatment for hypertension, male over time
- Iran
- Syria
How they compare
Syria currently reports 37.7% against 37.6% in Iran, a difference of 0.1%.
Across all 30 years both countries report, Syria has been ahead every year.
Iran ranks 82nd and Syria ranks 81st of 192 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran | Syria | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 16.6% | 18.3% | 1.7% | Syria |
| 2000s | 24.9% | 26.4% | 1.5% | Syria |
| 2010s | 35.1% | 35.4% | 0.3% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Iran or Syria?
- Syria, at 37.7% against 37.6% in Iran as of 2019.
- What is the difference in treatment for hypertension, male between Iran and Syria?
- 0.1%, with Syria ahead.
- How many years of comparable data are there for Iran and Syria?
- 30 years are reported by both, from 1990 to 2019.
- How do Iran and Syria rank globally for treatment for hypertension, male?
- Iran ranks 82nd and Syria ranks 81st of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.